Valenza offers individualized evaluation and treatment for medical weight management and hormone-related concerns. A consultation does not guarantee a prescription. Your clinician will recommend only the options that fit your clinical needs.
For eligible adults, treatment may include semaglutide, a GLP-1 receptor agonist, or tirzepatide, a dual GIP/GLP-1 receptor agonist.
These medications may reduce appetite, increase satiety, and support clinically meaningful weight loss when combined with nutrition, physical activity, resistance exercise, and other lifestyle measures.
Medication is generally considered for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with a clinically significant weight-related condition. These thresholds mainly apply when treatment begins.
Adult men with symptoms or clinical findings suggesting testosterone deficiency may be evaluated for testosterone replacement therapy.
A diagnosis should generally be supported by compatible symptoms or findings together with consistently low testosterone concentrations—ordinarily including two separate total testosterone measurements. A single symptom or one low result is not ordinarily enough.
Men with confirmed testosterone deficiency and no clinically significant contraindication may be offered TRT after discussion of potential benefits, risks, alternatives, fertility implications, and monitoring requirements.
Hormonal changes during perimenopause and menopause may affect sexual function, quality of life, and other aspects of health. Women with relevant symptoms may be offered an individualized hormonal evaluation.
Systemic testosterone therapy in women is generally off-label in the United States, and there are currently no FDA-approved testosterone products specifically indicated for women. The strongest evidence-based indication is hypoactive sexual desire disorder, particularly in postmenopausal women after appropriate evaluation of other contributing factors.
There is no universally accepted blood-test threshold that diagnoses ‘female testosterone deficiency.’ Baseline testosterone is used mainly to identify unexpected androgen excess, establish a reference, and support safety monitoring—not to make a diagnosis from a low number alone.
Body composition is more informative than scale weight alone.
Valenza may use weight, circumference measurements, photographs or 3D shape tracking, and other available tools to document change over time.
The purpose is to help patients focus on excess-fat reduction, lean-mass preservation, strength, function, and sustainable habits.
All treatment is subject to provider evaluation, eligibility, and clinical appropriateness. Prescription medication is not guaranteed. Individual results vary.
All treatment is subject to provider evaluation, eligibility, and clinical appropriateness. Prescription medication is not guaranteed. Individual results vary.